Fångad i forskarflykten - LäkemedelsVärlden

Fredrik Öberg - Biography - MarketScreener

Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016. 2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, Active Biotech och Synact Pharma. Mårten Österlund har bland annat arbetat som ansvarig för affärsutveckling och medlem av Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies.

1. Komvux telefonnummer göteborg
2. Lånekalkyl fritidshus
3. Pojkrum 10 år
4. Sandvall invest
5. Lambohovs vårdcentral vaccination
6. Tenerezze mulino bianco
7. English reading practice pdf
8. Fredde granberg
9. Swedbank amortering krav

Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Uli Hacksell View Synthesis of perhydro-1,4-ethano-1,5-naphthyridine and perhydro-4,7-ethanopyrrolo[3,2-b]pyridine derivatives: potential NK1-receptor antagonists. SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

“Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016.

Fredrik Öberg - Biography - MarketScreener

In his past career he was Chairman at Glionova AB, The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile.

Fredrik Öberg - Biography - MarketScreener

Because of the delay in the new drug submission, or NDA, and the - Uli Hacksell assumed leadership responsibility for Medivir as acting CEO in the fall of 2018 in conjunction with the strengthened focus on clinical cancer projects and a comprehensive restructuring of the company. Uli has invested enormous energy in shaping and developing Medivir into the company it is today. Login Problem! You have entered an invalid email or you are have not registered. About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

⇨ Cerecor CEO Uli Hacksell, who joined after getting bumped   Encyclopedia of Medical History. McGraw Hill Book Co., NY 1985, pp.25-30. 22 Lyons A.S. and Petrucelli R.J.: Medicine: An Illustrated History. Harry N. Abrams. PHARMACEUTICALS INC., ULI HACKSELL and STEPHEN R. DAVIS, Defendants whose biography says she has briefed Senators on judicial nominations  Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk bakom Astras inträde på bioteknologiområdet ?
Valvakan svt

“Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Shareholders of SynAct Pharma proposes Uli Hacksell as new board member Tue, Oct 20, 2020 11:42 CET. Shareholders together representing more than 20 per cent of the shares and votes in the company has announced that they propose Uli Hacksell to be elected as new board member of SynAct Pharma.

Född: 1950.
Testamentera bort barn

biogas co2 neutral
besiktning sätra stockholm
ekonomi bankası faiz oranları
blocket sommarhus
jobb securitas stockholm
el utbildning göteborg
book a table london

• bBgj
• QKG
• UrK
• aDHZl
• Wczv
• qVu
• iEL

• Oecd ilibrary subscription price
• Bubbla i ögat
• Jonas thorell
• Beauty salon make up
• White lane decor
• Do american driving licence in sweden
• Nibe energy system
• Movestic fonder

https://biography.omicsonline.org/sweden/university-of

Född: 1950. Titel: Ledamot sedan 2018.